Direct Quantitative Comparison Between [11C]UCB-J and [18F]SynVest-1 PET As Markers for Synaptic Density in Premanifest and Manifest Huntington's Disease
Latest Information Update: 17 Dec 2024
At a glance
- Drugs Carbon 11 UCB J (Primary) ; 18F-SynVest-1
- Indications Huntington's disease
- Focus Diagnostic use
Most Recent Events
- 13 Dec 2024 Planned End Date changed from 1 Dec 2025 to 1 Dec 2026.
- 13 Dec 2024 Planned primary completion date changed from 1 Dec 2025 to 1 Dec 2026.
- 13 Dec 2024 Status changed from not yet recruiting to recruiting.